MedTrace Logo

Evaluating the Efficacy of Voice Therapy for Neurogenic Voice Disorders

NCT07474740 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-16

No results posted yet for this study

Summary

The goal of this study is to evaluate the efficacy of voice therapy for neurogenic voice disorders. The main questions are:

Does voice therapy improve patient-reported quality of life in speakers with neurogenic voice disorders? Does voice therapy improve listener perception of voice in speakers with neurogenic voice disorders? Does voice therapy improve acoustical analyses of voice in speakers with neurogenic voice disorders? Does voice therapy improve physiologic function in speakers with neurogenic voice disorders?

Conditions

  • Speakers With Neurogenic Voice Disorders

Interventions

BEHAVIORAL

Breathy voice

Participants will be trained to produce a breathy voice to reduce the perceptual severity of vocal tremor

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Rosemary A Lester-Smith, Ph.D. · The University of Texas at Austin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-04
Primary Completion
2028-06-04
Completion
2028-06-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07474740 on ClinicalTrials.gov